Cite

HARVARD Citation

    Iwata, H. et al. (n.d.). 184ODistant disease-free survival (DDFS) according to response category in neoadjuvant endocrine therapy (NET): 6-year analysis in phase III NEOS trial. Annals of oncology. p. . [Online]. 
  
Back to record